Lisa Douet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lisa Douet has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Blatch-Jones
National Institute for Health and Care Research (NIHR) Coordinating Centre Southampton Hampshire SO167NS University of Southampton School of Healthcare Enterprise and Innovation
1 shared publication - Fay Chinnery
Southampton Clinical Trials Unit, University of Southampton, Southampton, UK
1 shared publication - Gemma Bashevoy
National Institute for Health Research (NIHR), Evaluation, Trials and Studies Coordinating Centre (NETSCC), University of Southampton, Southampton, SO16 7NS, UK
1 shared publication - James Raftery
Faculty of Medicine, University of Southampton, Highfield Campus, Southampton, UK
1 shared publication - Sarah Puddicombe
National Institute for Health Research (NIHR), Evaluation, Trials and Studies Coordinating Centre (NETSCC), University of Southampton, Southampton, SO16 7NS, UK
1 shared publication
Latest Publications
- Open Access
- 2 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 87
National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease
HTA Programme funding is governed by the need for evidence and scientific quality, reflecting funding of the National Institute for Health Research (NIHR) by the NHS. The need criterion incorporates covering the spectrum of diseases, but also taking account of research supported by other funders. This study compared the NIHR HTA Programme portfolio of research with the UK burden of disease as measured by Disability-adjusted Life Years (DALYs). A retrospective cross-sectional study using a cohort of all funded primary research and evidence syntheses projects received by the HTA Programme from April 2011 to March 2016 (n = 363); to determine the proportion of spend by disease compared with burden of disease in the UK calculated using 2015 UK DALY data. The programme costing just under £44 million broadly reflected UK DALY burden by disease. Spend was lower than disease burden for cancer, cardiovascular and musculoskeletal diseases, which may reflect the importance of other funders, notably medical charities, which concentrate on these diseases. The HTA Programme spend, adjusted for other relevant funders, broadly matches disease burden in the UK; no diseases are being neglected.
- 2 February 2018
- Published by Springer Nature in Trials
- Vol. 19 (1) , 87
Open AccessNational Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme research funding and UK burden of disease
HTA Programme funding is governed by the need for evidence and scientific quality, reflecting funding of the National Institute for Health Research (NIHR) by the NHS. The need criterion incorporates covering the spectrum of diseases, but also taking account of research supported by other funders. This study compared the NIHR HTA Programme portfolio of research with the UK burden of disease as measured by Disability-adjusted Life Years (DALYs). A retrospective cross-sectional study using a cohort of all funded primary research and evidence syntheses projects received by the HTA Programme from April 2011 to March 2016 (n = 363); to determine the proportion of spend by disease compared with burden of disease in the UK calculated using 2015 UK DALY data. The programme costing just under £44 million broadly reflected UK DALY burden by disease. Spend was lower than disease burden for cancer, cardiovascular and musculoskeletal diseases, which may reflect the importance of other funders, notably medical charities, which concentrate on these diseases. The HTA Programme spend, adjusted for other relevant funders, broadly matches disease burden in the UK; no diseases are being neglected.